As a result of Zero Gravity’s failure to respond to its inquiries, the National Advertising Division (NAD) has referred Zero Gravity’s claims for its Perfectio line of medical devices to the Federal Trade Commission (FTC) and...more
Editor’s Note: The promotional review process requires a critical balance between ensuring materials achieve business goals and complying with regulatory constraints. There often can be friction on the promotional review...more
Editor’s Note: The promotional review process requires a critical balance between ensuring materials achieve business goals and complying with regulatory constraints. There often can be friction on the promotional review...more
Editor’s Note: The promotional review process requires a critical balance between ensuring materials achieve business goals and complying with regulatory constraints. There often can be friction on the promotional review...more
How can you reduce conflict on the PRC and work together efficiently across different functions to achieve a common goal? What are the Food and Drug Administration (FDA) regulations you need to keep top of mind when...more
9/19/2019
/ Advertising ,
Best Practices ,
Brand ,
Commercial Success ,
Continuing Legal Education ,
Federal Trade Commission (FTC) ,
Food and Drug Administration (FDA) ,
Labeling ,
Life Sciences ,
Marketing ,
Pharmaceutical Industry ,
Regulatory Requirements ,
Risk Mitigation ,
Webinars
A Massachusetts federal court threw out a lawsuit against Honey Bunches of Oats brought by consumers who claimed that the product packaging and marketing misled them about the cereal’s honey content....more
A Washington, D.C., judge poured out an action from a vodka company over its advertising claims in an appeal from the Alcohol and Tobacco Tax and Trade Bureau (TTB)....more
On July 9, Judge Amit P. Mehta of the U.S. District Court, District of Columbia vacated an administration final rule that would have required drug manufacturers to disclose wholesale acquisition prices in their television...more
Editor’s Note: On May 8, the administration issued the much-anticipated final rule requiring drug manufacturers to disclose wholesale acquisition prices in their broadcast advertising. The debate around the rule has been...more